These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 4940647

  • 21. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    Tanghe A, Vereecken JL.
    Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564
    [No Abstract] [Full Text] [Related]

  • 22. [Long-acting neuroleptics. IV. Preliminary study of clopimozide (R 29764)].
    Bobon J, Parent M, Toussaint C, Pinchard A.
    Acta Psychiatr Belg; 1976; 76(1):138-43. PubMed ID: 970182
    [Abstract] [Full Text] [Related]

  • 23. [Clinical experimentation with a long-acting neuroleptic fluspirilene (R 6218)].
    Luyckx A.
    Acta Psychiatr Belg; 1972 Nov; 72(6):748-55. PubMed ID: 4679557
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical study of an original new neuroleptic drug: pimozide].
    Fouks L, Perivier E, Froge E, Houssait A, Mathis P, Ferragu Y.
    Cah Med; 1971 Dec 15; 12(16):1405-9. PubMed ID: 5145124
    [No Abstract] [Full Text] [Related]

  • 25. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J, Náhunek K.
    Act Nerv Super (Praha); 1972 Dec 15; 14(2):93-4. PubMed ID: 4557145
    [No Abstract] [Full Text] [Related]

  • 26. An international double-blind clinical evaluation of pimozide.
    Janssen P, Brugmans J, Dony J, Schuermans V.
    J Clin Pharmacol New Drugs; 1972 Jan 15; 12(1):26-34. PubMed ID: 4550223
    [No Abstract] [Full Text] [Related]

  • 27. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA, Niemegeers CJ, Schellekens KH, Dresse A, Lenaerts FM, Pinchard A, Schaper WK, van Nueten JM, Verbruggen FJ.
    Arzneimittelforschung; 1968 Mar 15; 18(3):261-79. PubMed ID: 4386815
    [No Abstract] [Full Text] [Related]

  • 28. [Some problems posed by double-blind investigation of psychotropic drugs: clinical trial of Nobrium Roche].
    Chistoni GC.
    Schweiz Arch Neurol Neurochir Psychiatr; 1971 Mar 15; 108(2):309-15. PubMed ID: 4941608
    [No Abstract] [Full Text] [Related]

  • 29. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A, Vereecken JL.
    Psychiatr Neurol Neurochir; 1971 Mar 15; 74(5):379-89. PubMed ID: 5138128
    [No Abstract] [Full Text] [Related]

  • 30. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM, Mielke DH, Spirtes MA, Swanson WC, Bost R.
    Am J Psychiatry; 1974 Jun 15; 131(6):699-702. PubMed ID: 4597305
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M.
    Osp Psichiatr; 1971 Jun 15; 39(2):399-407. PubMed ID: 4948707
    [No Abstract] [Full Text] [Related]

  • 32. [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].
    Mormont C.
    Acta Psychiatr Belg; 1972 Sep 15; 72(5):595-601. PubMed ID: 4669431
    [No Abstract] [Full Text] [Related]

  • 33. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B, Benson K, Grynaeus T.
    Int Pharmacopsychiatry; 1973 Sep 15; 8(1):37-59. PubMed ID: 4595192
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].
    Floru L, Zurborn R.
    Med Welt; 1973 Apr 13; 24(15):600-3. PubMed ID: 4744987
    [No Abstract] [Full Text] [Related]

  • 35. Therapeutic trials and EEG investigations with SCH-12,679 in behaviorally disturbed adolescents.
    Itil TM, Stock MJ, Duffy AD, Esquenazi A, Saleuty B, Han TH.
    Curr Ther Res Clin Exp; 1972 Mar 13; 14(3):136-50. PubMed ID: 4622893
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical evaluation of the TPN 12 (Sandoz) preparation in the treatment of mental disorders].
    Bukowczyk A, Korta B, Michalska M, Spisla B, Trzeciakowa O, Bryś J.
    Psychiatr Pol; 1971 Mar 13; 5(5):571-5. PubMed ID: 4400423
    [No Abstract] [Full Text] [Related]

  • 37. [Long-acting neuroleptic preparations and their use in mental disorders].
    Vovin RIa, Vovina EN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Mar 13; 72(6):920-4. PubMed ID: 5050052
    [No Abstract] [Full Text] [Related]

  • 38. Polypharmacy in psychiatry: empiricism, efficacy, and rationale.
    Merlis S, Beyel V, Fiorentino D, Fracchia J, Sheppard C.
    Curr Psychiatr Ther; 1972 Mar 13; 12():89-97. PubMed ID: 4555860
    [No Abstract] [Full Text] [Related]

  • 39. Prediction of neuroleptic effects from animal data.
    Vinar O, Krsiak M.
    Adv Biochem Psychopharmacol; 1974 Mar 13; 9(0):675-83. PubMed ID: 4836228
    [No Abstract] [Full Text] [Related]

  • 40. Quantitative pharmaco-electroencephalography in the discovery of a new group of psychotropic drugs.
    Itil TM.
    Dis Nerv Syst; 1972 Aug 13; 33(8):557-9. PubMed ID: 4405375
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.